1992
DOI: 10.1073/pnas.89.17.8268
|View full text |Cite
|
Sign up to set email alerts
|

Attenuation of GTPase activity of recombinant G(o) alpha by peptides representing sequence permutations of mastoparan.

Abstract: There is convincing evidence that the cyto.plasmnic domains of multisning receptors interact with guanine nucleotide-binding proteins (G proteins). What are the rules governing these interactions? In an attempt to answer this question, we focused our attention on mastoparan, an amphiphilic tetradecapeptide from wasp venom, and on nine of its variants, produced by sequence permutation, which have altered amphiphilicity or no amphiphilici at all. Mastoparan enhances the GTPase activity of recombinant G~a 5-fold … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

1993
1993
2021
2021

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 30 publications
(17 citation statements)
references
References 38 publications
0
17
0
Order By: Relevance
“…Mas7[Q4;Qll] is the best available control for excluding membrane-disturbing side effects: Mas17, which is commonly used for this purpose, does not assume an a-helical structure in the presence of membrane and thus binds to them only weakly (Higashijima et al, 1990). Two other Mas derivatives, the Mas-derived peptides 2 and 7 (Oppi et al, 1992), which do not stimulate G-proteins in vitro, were also inactive in the fusion assay.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Mas7[Q4;Qll] is the best available control for excluding membrane-disturbing side effects: Mas17, which is commonly used for this purpose, does not assume an a-helical structure in the presence of membrane and thus binds to them only weakly (Higashijima et al, 1990). Two other Mas derivatives, the Mas-derived peptides 2 and 7 (Oppi et al, 1992), which do not stimulate G-proteins in vitro, were also inactive in the fusion assay.…”
Section: Discussionmentioning
confidence: 99%
“…8 A). The mastoparan derivatives masX and mas7 (Higashijima et al, 1990) and synthetic mastoparan-derived peptide 8 (Oppi et al, 1992), previously shown to also be potent G-protein activators, inhibited inter-vacuole fusion with approximately the same efficiency as mastoparan. The synthetic mastoparan-derivative masl7 (Higashijima et al, 1990) and the mastoparan-derived peptides 2 and 7 (Oppi et al, 1992; data not shown for peptide 7), all of which do not stimulate G-proteins in vitro, inhibited fusion slightly and then only at high concentrations ( Fig.…”
Section: G-protein-activating Mastoparan Inhibits In Vitro Vacuole Fumentioning
confidence: 99%
See 1 more Smart Citation
“…The expression of recombinant Go~ was verified by SDS/PAGE of induced lysates on 12.5% slab gels according to Laemmli [12] after Coomassie blue staining, as well as after immunoblot analysis using a 1 : 10,000 dilution of a rabbit antiserum specific for Go0~ [13], provided by Dr. Graeme Milligan (University of Glasgow, Scotland). The purification of the recombinant G,,ot from bacterial lysates was carried out as previously reported [14]. The recombinant G~ot subunit (G~c~-s, 45 kDa form), purified according to a slightly modified protocol [15], was a gift from Drs.…”
Section: Recombinant Got Subunitsmentioning
confidence: 99%
“…Upon receptorligand interaction, GDP is exchanged for GTP on the G protein's ~-subunit, which subsequently dissociates from the receptor and the fl), dimer and modulates the activity of ion channels or effectors. Following GTP hydrolysis, GceGDP reassociates with fly on the inner surface of the cell membrane [14].…”
Section: Introductionmentioning
confidence: 99%